semaglutide hickory New Weight Loss Medication Wegovy™ Approved by the FDA Transform Your Life: Weight Loss

Emphasis is placed on clinical screening, controlled titration, and ongoing monitoring to align outcomes with safety parameters

Another article review reported that return to baseline gastric function requires cessation of GLP-1 RA use approximately five half-lives of the GLP-1 RA (Ushakumari and Sladen 2024)

Although MedVi has the clinical mechanisms that are available to support a tapering discussion with a patient, such as via the patient initiated 24/7 messaging system and the monthly refill review process, they are not systematically activated

Request a DEXA scan at baseline and 12 weeks to track lean mass changes, or use bioelectrical impedance analysis (BIA) if DEXA isn't accessible

References to clinical trials and published research throughout this description are provided for informational and research context only and do not constitute medical claims or endorsements of any therapeutic application of these products.

Many GLP-1 users lose weight faster than this, especially in the first 2-3 months